-

Independent Bank Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Independent Bank Corp. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – INDB

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of Independent Bank Corp. (NASDAQ: INDB) and Meridian Bancorp, Inc. is fair to Independent Bank shareholders. Meridian Bancorp shareholders are expected to receive Independent Bank stock in connection with the merger.

Halper Sadeh encourages Independent Bank shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.

The investigation concerns whether Independent Bank and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Independent Bank shareholders; and (2) disclose all material information necessary for Independent Bank shareholders to adequately assess and value the merger consideration.

Halper Sadeh encourages Independent Bank shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contacts

Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

Halper Sadeh LLP

NASDAQ:INDB

Release Versions

Contacts

Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

More News From Halper Sadeh LLP

MKC Stock Alert: Halper Sadeh LLC is Investigating Whether McCormick & Company, Incorporated is Obtaining a Fair Deal for its Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the merger of McCormick & Company, Incorporated (NYSE: MKC) and Unilever’s Foods business. Upon closing of the proposed transaction, McCormick shareholders will own 35.0% of the combined company. Halper Sadeh encourages McCormick shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or...

CNTA Stock Alert: Halper Sadeh LLC is Investigating Whether Centessa Pharmaceuticals plc is Obtaining a Fair Price for its Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Centessa Pharmaceuticals plc (NASDAQ: CNTA) to Eli Lilly and Company for $38.00 in cash per share plus one non-transferrable contingent value right entitling the holder to receive up to an aggregate of $9.00 subject to the achievement of certain milestones.Halper Sadeh encourages Centessa shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary...

APLS Stock Alert: Halper Sadeh LLC is Investigating Whether Apellis Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) to Biogen Inc. for $41.00 per share in cash and a nontransferable contingent value right for the right to receive two payments of $2.00 per share each, contingent on certain annual global net sales thresholds being met for SYFOVRE. Halper Sadeh encourages Apellis shareholders to click here to learn more about their rights and options or contact Dani...
Back to Newsroom